Skip to main content

Stem cell patent dispute: Wisc. fights back

In the fallout from a linkurl:major decision;https://www.the-scientist.com/news/home/53051/ by the US patent agency to reject key stem cell patents for embryonic linkurl:stem cell research;https://audio.wnyc.org/bl/bl010507d.mp3 held by the Wisconsin Alumni Research Foundation (WARF), Wisconsin Governor Jim Doyle has taken to the airwaves to defend the state's intellectual property. In a linkurl:statement;https://www.wisgov.state.wi.us/journal_media_detail.asp?locid=19&prid=2583 released yeste

Written byAlison McCook
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
In the fallout from a linkurl:major decision;https://www.the-scientist.com/news/home/53051/ by the US patent agency to reject key stem cell patents for embryonic linkurl:stem cell research;https://audio.wnyc.org/bl/bl010507d.mp3 held by the Wisconsin Alumni Research Foundation (WARF), Wisconsin Governor Jim Doyle has taken to the airwaves to defend the state's intellectual property. In a linkurl:statement;https://www.wisgov.state.wi.us/journal_media_detail.asp?locid=19&prid=2583 released yesterday (April 3), the governor reminded the public that the decision is only "preliminary," and the patents remain valid while the university goes through the appeal process. "Based on my many conversations with experts in the field over the past few years, I am confident that these patents will ultimately be upheld," Doyle said. WARF Managing Director Carl Gulbrandsen appears equally confident, if not more so, that the patents will prevail. When groups linkurl:first challenged;https://www.the-scientist.com/news/display/25037/ the patents, he called their case "ludicrous" in an interview with The Scientist. In a statement released by WARF following this week's decision, Gulbrandsen said it was "inconceivable" that the research performed by Wisconsin biologist James Thomson was not worthy of a patent. Financially, WARF has fared quite well -- in 2005-2006, the organization linkurl:funded;https://www.warf.org/about/index.jsp?cid=27&scid=36 $65 million worth of research at the University of Wisconsin. You can share your thoughts about WARF's odds of reversing the US Patent and Trademark Office's decision here.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays